Close
ACHEMA MIDDLE EAST 2026

Analytics & Mass Spec Enable Biotherapeutic Drug Development

In the modern era, biopharmaceutical discovery and development scientists happen to be achieving new levels when it comes to structural insight into therapeutic proteins....

Biopharma Commits Offering Equitable Access In Pandemics

The 77th World Health Assembly- WHA goes on to mark the deadline for the conclusion of a pandemic agreement as well as amended International...

The Clinical Trial Participation Added More Seamlessness

Verified Clinical Trials is all set to integrate its research participation verification tools with the clinical trial automation platform of ProofPilot in a new...

Amid Registry Patent Listing Action, Drug Clashes Continue

No company happened to be hit harder by the US Federal Trade Commission’s crackdown when it came to patents listed on the federal registry...

Successful Scale-Up of Cell-Gene Therapy With Platform Tech

It is a well-known fact that the Cell and Gene Therapy platforms involve the most intricate production and delivery requirements if we talk about...

NHS Gives Its Nod To New Endometrial Cancer Immunotherapy

The NHS is all set to come up with groundbreaking immunotherapy that can go on to potentially offer a significant additional time when it...

UK Research On Crohns Disease Treatment For Better Outcomes

Top-down treatment by way of infliximab Plus, which is an immunomodulator, goes on to substantially enhance the outcomes for patients with newly diagnosed Crohn’s...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...